BRCA1 and ovarian cancer: Another study showed that promoter methylation levels of BRCA1, a key gene involved in DNA repair, were higher in CDDP-resistant ovarian cancer cell lines and that exposure to a demethylating agent sensitized those cells to platinum treatment [107].